Keyphrases
Stimulator of Interferon Genes (STING)
100%
Melanoma
100%
Gene Deficiency
100%
Oncolytic Virus
100%
Immunogenic Cell Death
100%
Viral Immunotherapy
100%
Talimogene Laherparepvec (T-VEC)
100%
Tumor
30%
Melanoma Cells
30%
Tumor Immunity
20%
Therapeutic Response
20%
Mechanism of Action
10%
Gene Expression
10%
Effector Memory T Cells
10%
Cell Activation
10%
Inflammatory Genes
10%
Granulocyte Colony-stimulating Factor (G-CSF)
10%
T Cell Regulation
10%
Viral Antigens
10%
Therapeutic Action
10%
CD8+ T Cells
10%
Gene Signature
10%
Antigen-specific
10%
Herpes Simplex Virus Type 1 (HSV-1)
10%
Cell Killing
10%
Gene Knockout
10%
Translocated
10%
Tumor Microenvironment
10%
Melanoma Treatment
10%
Cas9 Protein
10%
Tumor Antigen
10%
Antitumor Activity
10%
High Mobility Group Box 1 (HMGB1)
10%
Low Expression
10%
Relative Sensitivity
10%
Cell Sensitivity
10%
Clinical Development
10%
Calreticulin
10%
Murine Tumors
10%
Melanoma Model
10%
Gene Express
10%
T Cell Infiltration
10%
Oncolysis
10%
Anti-PD-1
10%
Oncolytic Herpes Simplex Virus (oHSV)
10%
PD-1 Blockade Therapy
10%
Medicine and Dentistry
Interferon
100%
Immunotherapy
100%
Oncolytic Virus
100%
Immunogenic Cell Death
100%
Talimogene Laherparepvec
100%
Melanoma
100%
Neoplasm
36%
In Vitro
18%
Treatment Response
18%
Cytotoxic T-Cell
18%
Tumor Immunity
18%
Melanoma Cell Line
18%
Infection
9%
Gene Expression
9%
T Cell
9%
Mediator
9%
Cell Activation
9%
Adenosine Triphosphate
9%
Tumor Microenvironment
9%
Tumor Antigen
9%
Melanoma Cell
9%
Cellular Infiltration
9%
Human Alphaherpesvirus 1
9%
Antineoplastic Activity
9%
Granulocyte Macrophage Colony Stimulating Factor
9%
Cell Killing
9%
Calreticulin
9%
Cas9
9%
Clustered Regularly Interspaced Short Palindromic Repeat
9%
Oncolytic Herpes Virus
9%
T Cell Regulation
9%
Immunology and Microbiology
Cell Death
100%
Immunotherapy
100%
Oncolytic Virus
100%
Stimulator of Interferon Genes
100%
Talimogene Laherparepvec
100%
Cytotoxic T-Cell
18%
Tumor Immunity
18%
Melanoma Cell Line
18%
T Cell
9%
Gene Expression
9%
Mediator
9%
Cell Activation
9%
T Cell Regulation
9%
Human Alphaherpesvirus 1
9%
Granulocyte Macrophage Colony-Stimulating Factor
9%
Murine
9%
CRISPR/Cas9
9%
Tumor Antigen
9%
Melanoma Cell
9%
Cell Killing
9%
Antineoplastic Activity
9%
Cell Infiltration
9%
Calreticulin
9%
Oncolytic Herpes Virus
9%